M15-997
Laufzeit: 01.01.2018 - 31.12.2018
imported
Kurzfassung
A multicenter, open label study to assess the safelty and efficacy of risankizumab for maintenance in moderate to severe plaque type psoriasis
Laufzeit: 01.01.2018 - 31.12.2018
A multicenter, open label study to assess the safelty and efficacy of risankizumab for maintenance in moderate to severe plaque type psoriasis
